| ASSET | YEARS | % RETURN |
|---|---|---|
Mesoblast (MESO) | 2004-2024 | 19,799,900% |
QXO (QXO) | 2004-2024 | 7,949,900% |
Fractyl Health, Inc Common Stock (GUTS) | 2004-2024 | 3,531,328.57% |
Avita Medical (RCEL) | 2004-2024 | 3,199,900% |
OPTIMIZERx (OPRX) | 2004-2024 | 2,429,900% |
Northern Oil & Gas (NOG) | 2004-2024 | 1,365,837.5% |
ACCESS Newswire (ACCS) | 2004-2024 | 993,233.33% |
Scienture (SCNX) | 2004-2024 | 759,950.25% |
Lunai Bioworks (LNAI) | 2004-2024 | 711,389.36% |
Lexaria Bioscience (LEXX) | 2004-2024 | 470,049.25% |
CleanSpark (CLSK) | 2004-2024 | 460,400% |
Addex Therapeutics (ADXN) | 2004-2024 | 388,788.89% |
LiveOne (LVO) | 2004-2024 | 293,900% |
Evogene (EVGN) | 2004-2024 | 267,042.86% |
MDxHealth (MDXH) | 2004-2024 | 263,233.33% |
Xcel Brands (XELB) | 2004-2024 | 257,400% |
Fubotv (FUBO) | 2004-2024 | 251,900% |
Altimmune (ALT) | 2004-2024 | 248,520.69% |
Akari Therapeutics (AKTX) | 2004-2024 | 195,100% |
A2Z Smart Technologies (AZ) | 2004-2024 | 178,818.92% |
Integra Resources (ITRG) | 2004-2024 | 173,900% |
Immatics (IMTX) | 2004-2024 | 142,100% |
Cenntro Electric (CENN) | 2004-2024 | 140,074.67% |
Universal Insurance (UVE) | 2004-2024 | 122,817.58% |
Oramed Pharmaceuticals (ORMP) | 2004-2024 | 77,693.1% |
